News
ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing
ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing Today [...]
ArgusEye introduces AugaOne™ to accelerate downstream bioprocess development
ArgusEye Introduces AugaOne™ to Accelerate Downstream Bioprocess Development • [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™! [...]
ArgusEye at NLS Days 2019, September 10-12
ArgusEye at NLS Days 2019, September 10-12 ArgusEye’s CEO Dr. Erik Martinsson will participate at the Nordic Life Science Days 2019 Nordic Life Science Days 2019 will take place on September 10-12 in Malmö, Sweden. ArgusEye’s CEO Dr. Erik Martinsson will be participating [...]
ArgusEye Receives New Grant from Vinnova
ArgusEye Receives New Grant from Vinnova In tough competition with other innovative start-up companies, ArgusEye is granted 900 000 SEK from Vinnova’s program Innovative Startups Step 2. In September 2017, ArgusEye received a grant through Vinnova’s program Innovative Startups Step 1. The [...]
ArgusEye is Granted 500 000 SEK from Vinnova
ArgusEye is Granted 500 000 SEK from Vinnova ArgusEye AB is granted 500 000 SEK from Vinnova’s Runner Up program for the project ”ArgusEye – driving the revolution in manufacturing of biopharmaceuticals”. ArgusEye obtained high scores for their application to EU’s framework [...]